guidelines for disease-modifying therapy in ms
Published 5 years ago • 825 plays • Length 4:39Download video MP4
Download video MP3
Similar videos
-
20:42
aan releases guideline: disease-modifying therapies for adults with multiple sclerosis
-
2:07
guideline: disease modifying therapies for multiple sclerosis - american academy of neurology
-
31:37
highly effective disease-modifying therapies for multiple sclerosis
-
14:49
“choosing the right disease-modifying therapy,” geeta ganesh, m.d.
-
1:05:12
disease modifying therapies in multiple sclerosis
-
58:42
debate on the nhs england algorithm for ms treatment by disease-modifying drugs
-
3:56
disease modifying therapy for ms: when to dump your ms drug
-
34:38
overview and update on disease modifying therapies in multiple sclerosis
-
2:56
balancing efficacy and safety with ms disease modifying therapies
-
3:01
disease-modifying therapies for ms during covid-19
-
4:28
switching therapy in multiple sclerosis
-
55:48
webinar: the impact of covid-19 on multiple sclerosis management
-
5:23
when to upgrade an ms disease modifying therapy [all 5 reasons]
-
1:52
patricia coyle, md: needed improvements in multiple sclerosis
-
6:42
optimizing the use of disease modifying therapy in multiple sclerosis
-
3:06
the timing and choice of dmts for ms patients
-
48:29
mri for monitoring response to ms disease-modifying therapies | ms academy webinar
-
45:02
clinical implications of late-breaking data on disease modifying therapies for ms management
-
2:15
a pni minute | disease modifying therapies (dmts) for the treatment of multiple sclerosis